Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Watchlist Manager
Zylox-Tonbridge Medical Technology Co Ltd Logo
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Watchlist
Price: 15.94 HKD -1.6%
Market Cap: 5.2B HKD

Zylox-Tonbridge Medical Technology Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zylox-Tonbridge Medical Technology Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Accrued Liabilities
ÂĄ70.2m
CAGR 3-Years
19%
CAGR 5-Years
55%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Accrued Liabilities
ÂĄ132.8m
CAGR 3-Years
41%
CAGR 5-Years
42%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Accrued Liabilities
ÂĄ204m
CAGR 3-Years
18%
CAGR 5-Years
30%
CAGR 10-Years
42%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Accrued Liabilities
ÂĄ3B
CAGR 3-Years
14%
CAGR 5-Years
17%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Accrued Liabilities
ÂĄ62.3m
CAGR 3-Years
-2%
CAGR 5-Years
-11%
CAGR 10-Years
17%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Accrued Liabilities
ÂĄ879.6m
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Zylox-Tonbridge Medical Technology Co Ltd
Glance View

Market Cap
5.2B HKD
Industry
Health Care

Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.

Intrinsic Value
14.63 HKD
Overvaluation 8%
Intrinsic Value
Price

See Also

What is Zylox-Tonbridge Medical Technology Co Ltd's Accrued Liabilities?
Accrued Liabilities
70.2m CNY

Based on the financial report for Dec 31, 2024, Zylox-Tonbridge Medical Technology Co Ltd's Accrued Liabilities amounts to 70.2m CNY.

What is Zylox-Tonbridge Medical Technology Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
55%

Over the last year, the Accrued Liabilities growth was 0%. The average annual Accrued Liabilities growth rates for Zylox-Tonbridge Medical Technology Co Ltd have been 19% over the past three years , 55% over the past five years .

Back to Top